Craig — these are your words: “Anyone on this board

New Post Public Reply Private Reply Replies (1) Message Board
Katangolo craigakess #156985
547
Craig — these are your words:

“Anyone on this board who is realistic has 'support with a shrug' including certain mods who are long but clearly state that they are frustrated with the lack of any fundamental data or information in over a year. If you're not, well, then you just invested too much and are praying that EVERY silence means we're in partner discussions.

The Munich and Barcelona posters were lovely, maybe even had glitter and puffy stickers on them, but you want 'counter data?' Ok, look at the SP. The SP does not tell you what Craig or Katangolo or Respert think, it tells you what the WORLD thinks right now.

And YES, I hope it will change, but after a year of silence and knowing how a lot of deals are made, no one is in a quiet period for a year or even 6 months.

Shrugging and long.”

That’s sentiment. That’s your focus.

Here’s mine: science.
I’ve already shown you data from peer-reviewed journals, case reports, and clinical experiences across multiple disease states where CCR5 blockade demonstrated meaningful impact — transplant survival, ECMO recovery, inflammatory disease modulation, oncology tumor microenvironment, neuroinflammation, liver fibrosis.

So we’re not talking about glitter posters or stock price “shrugs.” We’re talking about human lives and peer-reviewed biology.

When you’re ready to move beyond sentiment and actually engage with science, let me know. Until then, I’ll stay where the evidence is.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Russel Metals Shows Strong Performance in Latest Earnings Report

Updated Category News Views 240

Russel Metals Inc. Reports Third Quarter Results for 2025 Russel Metals Inc. (TSX:RUS) has recently shared its financial performance for the three-month period ending September 30, 2025. The results reflect a positive trajectory in revenue and strategic initiatives to enhance its market position. Key Financial Metrics Overview In this quarter, Russel Metals has...

Continue Reading
KBC Group Shows Strong Capital Resilience Ahead of Changes

Updated Category News Views 257

KBC Group's Capital Position Remains Strong KBC Group has reported a robust standing in its capital levels, significantly exceeding the minimum capital requirements mandated by the European Central Bank (ECB). As part of the Supervisory Review and Evaluation Process (SREP) scheduled for the upcoming year, KBC received formal notification regarding its capital metrics....

Continue Reading
Synlogic's Q3 Financial Update Highlights Strategic Review

Updated Category News Views 79

Synlogic Provides Third Quarter 2024 Financial Results Synlogic, Inc. (NASDAQ: SYBX), a prominent biopharmaceutical firm dedicated to developing innovative therapeutics for serious diseases, has recently outlined its financial performance for the third quarter of 2024. The organization is actively working on advancing its mission to enhance healthcare through...

Continue Reading
Incannex Healthcare Sees Growth with Positive Fiscal Results

Updated Category News Views 98

Incannex Healthcare's Remarkable Financial Progress Incannex Healthcare Inc. (NASDAQ: IXHL) is making impressive strides in the biopharmaceutical world, focusing on breakthrough treatments for chronic diseases. Their recent fiscal year report outlines not only financial outcomes but also a plethora of operational and clinical advancements aimed at addressing significant...

Continue Reading
Revolutionizing Finance with ChatAnalyst at Alpha Liquid Terminal

Updated Category News Views 167

Alpha Liquid Terminal Introduces ChatAnalyst Financial Agent Recently, a game-changing tool was launched that promises to redefine how individuals manage and interpret financial data. This is powered by the innovative company, Alpha Liquid Terminal. The newly unveiled AI-driven financial analyst agent, known as ChatAnalyst, is designed to simplify and streamline financial...

Continue Reading